Increasing neopterin and decreasing endothelin-1 in plasma during insulin infusion in women

REFERENCES

• Prentice R, Szatrowski T, Kato H, Mason M. Leukocyte counts and cerebrovascular disease, J Chronic Dis 1982; 35: 703–14.
   Google Scholar
• Kochanek P, Hallenbeck J. Polymorphonuclear leukocytes and monocytes / macrophages in the pathogenesis of cerebral ischaemia and stroke, Stroke 1992; 23: 1367–79.
   Google Scholar
• Belch J. The relationship between white blood cells and arterial disease, Curr Opin Lipidol 1994; 5: 440 — 6.
   Google Scholar
• Ridker P, Cushman M, Stampfer M, Tracy R, Hennekens C. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men, N Engl J Med 1997; 336: 973–9.
   Google Scholar
• Kojima S, Icho T, Kajiwara Y, Kubota K. Neopterin as an endogenous antioxidant, FEBS letters 1992; 304: 163–6.
   PubMed Web of Science ®Google Scholar
• Fuchs D, Hausen A, Reibnegger G, Werner ER, Dierich MP, Wachter H. Neopterin as a marker for cell-mediated immunity, Immunol Today 1988; 9: 150–5.
   Google Scholar
• Huber C, Batchelor JR, Fuchs D, Hausen A, Lang A, Niederweiser D, Reibnegger G, Swetly P, Troppmaier J, Wachter H. Immune-response associated production of neopterin. Release from macrophages primarily under control of interferon gamma, J Exp Med 1984; 160: 310–6.
   Google Scholar
• Tatzber F, Rabl H, Koriska K, Erhart U, Puhl H, Waeg G, Krebs A, Esterbauer H. Elevated serum neopterin levels in atherosclerosis, Atherosclerosis 1991; 89: 203–8.
   PubMed Web of Science ®Google Scholar
• Nerup J, Andersen 00, Bendixen G, Egeberg J, Poulsen J. Antipancreatic cellular hypersensitivity in diabetes mellitus, Diabetes 1971; 20: 424–7.
   Google Scholar
• De Berardinis P, James RFL, Wise PH, Londei M, Lake SP, Feldmann M. Do CD4-positive cyto-toxic T-cells damage islet 13 cells in Type 1 diabetes? Lancet 1988; i: 823–4.
   Google Scholar
• Mandrup-Poulsen T, Bendtzen K, Nerup J, Dinarello CA, Svenson M, Nielsen JH. Affinity-purified human interleukin I is cytotoxic to isolated islets of Langerhans, Diabetologia 1986; 29: 63–7.
   Google Scholar
• Foulis AK, Farquharson MA, Meager A. Immunoreactive-alpha-interferonininsulin-secreting 13 cells in Type 1 diabetes mellitus, Lancet 1987; ii: 1423–7.
   Google Scholar
• Moutschen M, Schenn A, Lefebvre P. Impaired immune responses in diabetes mellitus: analysis of the factors and mechanisms involved. Relevance to the increased susceptibility of diabetic patients to specific infections, Diabete Metab 1992; 18: 187–208.
   Google Scholar
• Delamaire M, Maugendre D, Moreno M, Le Goff M-C, Allannic H, Genetet B. Impaired leukocyte function in diabetic patients, Diabetic Med 1997; 14: 29–34.
   PubMed Web of Science ®Google Scholar
• Baron A. Cardiovascular actions of insulin in humans: implications for insulin sensitivity and vascular tone, Baillieres Clin Endocrinol Metab 1993; 7: 961–87.
   Google Scholar
• Hulthén UL, Endre T, Mattiasson I, Berglund G. Insulin and forearm vasodilatation in hyper-tension-prone men, Hypertension 1995; 25: 214–8.
   Google Scholar
• Scherrer U, Randin D, Vollenweider P, Vollenweider L, Nicod P. Nitric oxide release accounts for insulin's vascular effects in humans, J Clin Invest 1994; 94: 2511–5.
   Google Scholar
• Hiramatsu K, Nozaki H, Arimori A. Reduction of platelet aggregation induced by euglycaemic insu-lin clamp, Diabetologia 1987; 30: 310–3.
   Google Scholar
• Trovati M, Anfossi G, Cavalot F, Massucco P, Bosia A, Emanuelli G. Insulin directly reduces platelet sensitivity to aggregating agents: studies in vitro and in vivo, Diabetes 1988; 37: 780–6.
   Google Scholar
• Radomski M, Palmer R, Moncada S. The role of nitric oxide and cyclic GMP in platelet adhesion to vascular endothelium, Biochem Biophys Res Commun 1987; 148: 1482–9.
   Google Scholar
• Radomski M, Palmer R, Moncada S. Endogenous nitric oxide inhibit human platelet adhesion to vascular endothelium, Lancet 1987; II: 1057–8.
   Google Scholar
• Ware J, Heistad D. Platelet-endothelium inter-actions, N Engl J Med 1993; 328: 628–35.
   PubMed Web of Science ®Google Scholar
• Moncada S, Higgs A. The L-arginine-nitric oxide pathway, N Engl J Med 1993; 329: 2002— 12.
   Google Scholar
• Yanagisawa M, Kurihara H, Kimura S, Tomobe Y, Kobayashi M, Mitsui Y, et al. A novel potent vasoconstrictor peptide produced by vascular endothelial cells, Nature 1988; 332: 411–5.
   Google Scholar
• Battistini B, D'Orléans-Juste P, Sirois P. Endothe-lins: Circulating plasma levels and presence in other biologic fluids, Lab Invest 1993; 68: 600–28.
   Google Scholar
• Trovati M, Massucco P, Mattiello L, Mularoni E, Cavalot F, Anfossi G. Insulin increases guanosine-3',5'-cyclic monophosphate in human platelets, a mechanism involved in the insulin anti-aggregating effect, Diabetes 1994; 43: 1015–9.
   Google Scholar
• Trovati M, Massucco P, Mattiello L, Piretto V, Cavalot F, Mularoni E. The insulin-induced increase of guanosine-3',5'-cyclic monophosphate in human platelets is mediated by nitric oxide, Diabetes 1996; 45: 768–70.
   Google Scholar
• Trovati M, Anfossi G, Massucco P, Mattiello L, Costamagna C, Piretto V, et al. Insulin stimulates nitric oxide synthesis in human platelets and, through nitric oxide, increases platelet concentra-tions of both guanosine-3',5'-cyclic monophos-phate and adenosine-3',5'-cyclic monophosphate, Diabetes 1997; 46: 742–9.
   Google Scholar
• Tschoepe D, Driesch E, Schwippert B, Nieuwenhuis H, Gries F. Exposure of adhesion molecules on activated platelets in patients with newly diagnosed IDDM is not normalized by near-normoglycemia, Diabetes 1995; 44: 890–4.
   Google Scholar
• Kulseng B, Skjak-Braek G, Folling I, Espevik T. TNF production from peripheral blood mono-nuclear cells in diabetic patients after stimulation with alginate and lipopolysaccharide, Scand J Immunol 1996; 43: 335–40.
   Google Scholar
• Tschoepe D, Driesch E, Schwippert B, Lampeter E. Activated platelets in subjects at increased risk of IDDM, Diabetologia 1997; 40: 573–7.
   Google Scholar
• Polderman K, Stehouwer C, Kamp Gv, Gooren L. Effects of insulin infusion on endothelium-derived vasoactive substances, Diabetologia 1996; 39: 1284— 92.
   Google Scholar
• Ferri C, Carlomagno A, Coassin S, Baldoncini R, Faldetta MC, Laurenti 0, et al. Circulating endothelin-1 levels increase during euglycaemic hyperinsulinemic clamp in lean NIDDM men, Diabetes Care 1995; 18: 226–33.
   Google Scholar
• Piatti P, Monti L, Conti M, Baruffaldi L, Galli L, Phan C, et al. Hypertriglyceridemia and hyper-insulinemia are potent inducers of endothelin-1 release in humans, Diabetes 1996; 45: 316–21.
   Google Scholar
• Kelly R, Smith T. Cytokines and cardiac con-tractile function, Circulation 1997; 95: 778–81.
   Google Scholar
• Salvemini D, DeNucci G, Gryglewski R, Vane J. Human neutrophils and mononuclear cells inhibit platelet aggregation by releasing a nitric oxide-like factor, Proc Natl Acad Sci USA 1989; 86: 6328 — 32.
   Google Scholar
• Nicolini F, Wilson A, Mehta P, Mehta J. Comparatory platelet inhibitory effects of human neutrophils and lymphocytes, J Lab Clin Med 1990; 116: 147–50.
   Google Scholar
• Zatta A, Prodoscimi M, Bertele M, Bazazoni G, Maschio AD. Inhibition of platelet function by polymorphonuclear leukocytes, J Lab Clin Med 1990; 116: 651–60.
   Google Scholar
• Maschio AD, Evangelista V, Rajtor G, Chen Z, Cerletti C, Gaetano GD. Platelet activation by polymorphonuclear leukocytes exposed to chemo-tactic agents, Am J Physiol (Heart Circ Physiol 27) 1990; 258: H870–9.
   Google Scholar
• Nagase S, Takemura K, Ueda A, Hirayama A, Aoyagi K, Kondoh M, et al. A novel non-enzymatic pathway for the generation of nitric oxide by the reaction of hydrogen peroxide and D-or L-Arginine, Biochem Biophys Res Commun 1997; 233: 150–3.
   Google Scholar
• Chowienczyk P, Ritter J. Arginine: NO more than a simple amino acid? Lancet 1997; 350: 901–2.
   PubMed Web of Science ®Google Scholar
• Wiedemann CJ, Beimpold H, Herold M, Knapp E, Braunsteiner H. Increased levels of serum neopterin and decreased production of neutrophil superoxide anions in chronic heart failure with elevated levels of tumor necrosis factor-alpha, J Am Coll Cardiol 1993; 22: 1897–901.
   Google Scholar
• Gross SS, Levi R. Tetrahydrobiopterin synthesis. An absolute requirement for cytokine-induced nitric oxide generation by vascular smooth muscle, J Biol Chem 1992; 267: 25722–9.
   Google Scholar
• Sakai N, Kaufman S, Milstein S. Tetrahydrobiop-terin is required for cytokine-induced nitric oxide production in a murine macrophage cell line, Mol Pharmacol 1993; 43: 6–10.
   Google Scholar
• Werner FG, Werner ER, Fuchs D, Hansen A, Reibnegger D, Wachter H. Tetrahydrobiopterin-dependent formation of nitrite and nitrate in murine fibroblasts, J Exp Med 1990; 172: 1599–607.
   Google Scholar
• DeFronzo R, Tobin J, Andrs R. Glucose clamp technique: a method for quantifying insulin secretion and resistance, Am J Physiol 1979; 237: E214–23.
   Google Scholar
• Mattiasson I, Berntorp K, Lindgärde F. Insulin resistance and Na/K-ATPase in hypertension in women: a difference in mechanism depending on level of glucose tolerance, Clin Sci 1992; 82: 105–11.
   Google Scholar
• Endre T, Mattiasson I, Hulthén UL, Berglund G. Insulin resistance is coupled to low physical fitness in normotensive men with a family history of hypertension, J Hypertens 1994; 12: 81–8.
   Google Scholar
• Brooker G, Harper J, Terasaki W, Moylan R. Radioimmunoassay of cyclic AMP and cyclic GMP; vol 10: 1–32. In: Brooker G, Greengard P, Robison G, ed. Advances in cyclic nucleotide research. New York: Raven Press
   Google Scholar
• Nielson C, Hindson D. Inhibition of polymorpho-nuclear leukocyte respiratory burst by elevated glucose concentrations in vitro, Diabetes1989; 38: 1031— 5.
   Google Scholar
• Kantar A, Wilkins G, Swoboda B, Littarru G, Bertoli E, Catassi C, et al. Alterations of the respiratory burst of polymorphonuclear leukocytes from diabetic children, Acta Pediatr Scand 1990; 79: 535–41.
   Google Scholar
• Marhoffer W, Stein M, Maeser E, Federlin K. Impairment of polymorphonuclear leukocyte func-tion and metabolic control of diabetes, Diabetes Care 1992; 15: 256–60.
   PubMed Web of Science ®Google Scholar
• Rayfield E, Ault M, Keusch G, Brothers M, Nechemias C, Smith H. Infection and diabetes: The case for glucose control, Am J Med 1982; 72: 439— 50.
   Google Scholar
• Shah SC, Malone JI, Simpson NE. A randomized trail of intensive insulin therapy in newly diag-nosed insulin-dependent diabetes mellitus, New Eng J Med 1989; 320: 550–4.
   Google Scholar
• Shah S, Malone J, Maclaren N, Riley W, Spillar R. High dose insulin therapy (HDIT) resulted in long term survival of beta cells and disappearance of islet cell antibodies (ICA) in IDDM, Diabetes 1991; 40 Suppl 1: 152 A.
   Google Scholar
• Laakso M, Edelman S, Bretchel G, Baron A. Impaired insulin-mediated skeletal muscle blood flow in patients with NIDDM, Diabetes 1992; 41: 1076— 83.
   Google Scholar
• Wolpert H, Steen S, Istfan N, Simonson D. Insulin modulates circulating endothelin-1 levels in humans, Metab Clin Exp 1993; 8: 1027–30.
   Google Scholar
• Anwaar I, Gottsäter A, Ohlsson K, Mattiasson I, Lindgärde F. Increasing levels of leukocyte derived inflammatory mediators in plasma and cAMP in platelets during follow-up after acute cerebral ischaemia, Cerebrovasc Dis 1998; 8: 310–7.
   Google Scholar
• Anwaar I, Gottsäter A, Wallmark A, Hedblad B, Lindgärde F, Mattiasson I. Intraplatelet cyclic 3'-5' guanosine monophosphate is related to serum cholesterol, Int Angiol 1996; 15: 201–6.
   Google Scholar